Development of a multiple-drug delivery implant for intraocular management of proliferative vitreoretinopathy
- 28 October 1998
- journal article
- Published by Elsevier
- Vol. 55 (2-3) , 281-295
- https://doi.org/10.1016/s0168-3659(98)00061-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Pathogenic Mechanisms in Proliferative VitreoretinopathyArchives of Ophthalmology (1950), 1997
- Surgical Treatment for Chronic Hypotony and Anterior Proliferative VitreoretinopathyAmerican Journal of Ophthalmology, 1996
- Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment.British Journal of Ophthalmology, 1995
- Suppression of experimental proliferative vitreoretinopathy by sustained intraocular delivery of 5-FUInternational Ophthalmology, 1995
- Proliferative VitreoretinopathyInternational Ophthalmology Clinics, 1995
- Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathyCurrent Eye Research, 1995
- Prevention of Experimental Proliferative Vitreoretinopathy With a Biodegradable Intravitreal Implant for the Sustained Release of FluorouracilArchives of Ophthalmology (1950), 1994
- Effects of an Intravitreal Daunomycin Implant on Experimental Proliferative Vitreoretinopathy: Simultaneous Pharmacokinetic and Pharmacodynamic EvaluationsJournal of Ocular Pharmacology and Therapeutics, 1994
- UPTAKE AND CLEARANCE OF 5-FLUOROURIDINE FOLLOWING SUBCONJUNCTIVAL AND INTRAVITREAL INJECTIONRetina, 1988
- Results of Conventional Vitreous Surgery for Proliferative VitreoretinopathyAmerican Journal of Ophthalmology, 1985